Skip to main content
Top
Published in: Malaria Journal 1/2019

Open Access 01-12-2019 | Malaria | Case report

Plasmodium vivax severe imported malaria in two migrants in France

Authors: Arezki Izri, Sandrine Cojean, Claire Leblanc, Yves Cohen, Olivier Bouchaud, Rémy Durand

Published in: Malaria Journal | Issue 1/2019

Login to get access

Abstract

Background

With less than one severe case per year in average, Plasmodium vivax is very rarely associated with severe imported malaria in France. Two cases of P. vivax severe malaria occurred in patients with no evident co-morbidity. Interestingly, both cases did not occur at the primary infection but during relapses.

Case presentations

Patient 1: A 27-year old male, born in Afghanistan and living in France since 2012, was admitted on August 2015 to the Avicenne hospital because of abdominal pain, intense headache, fever and hypotension. The patient was haemodynamically unstable despite 5 L of filling solution. A thin blood film showed P. vivax trophozoites within the red blood cells. To take care of the septic shock, the patient was given rapid fluid resuscitation, norepinephrine (0.5 mg/h), and intravenous artesunate. Nested polymerase chain reactions of the SSUrRNA gene were negative for Plasmodium falciparum but positive for P. vivax. The patient became apyretic in less than 24H and the parasitaemia was negative at the same time. Patient 2: A 24-year old male, born in Pakistan and living in France, was admitted on August 2016 because of fever, abdominal pain, headache, myalgia, and nausea. The last travel of the patient in a malaria endemic area occurred in 2013. A thin blood film showed P. vivax trophozoites within the red blood cells. The patient was treated orally by dihydroartemisinin-piperaquine and recovered rapidly. Nine months later, the patient returned to the hospital with a relapse of P. vivax malaria. The malaria episode was uncomplicated and the patient recovered rapidly. Three months later, the patient came back again with a third episode of P. vivax malaria. Following a rapid haemodynamic deterioration, the patient was transferred to the intensive care unit of the hospital. In all the patient received 10 L of filling solution to manage the septic shock. After 5 days of hospitalization and a specific treatment, the patient was discharged in good clinical conditions.

Conclusion

Clinicians should be aware of the potential severe complications associated with P. vivax in imported malaria, even though the primary infection is uncomplicated.
Literature
1.
go back to reference Kendjo E, Houzé S, Mouri O, Taieb A, Gay F, Jauréguiberry S, et al. Epidemiologic trends in malaria incidence among travelers returning to Metropolitan France, 1996–2016. JAMA Netw Open. 2019;2:e191691.CrossRef Kendjo E, Houzé S, Mouri O, Taieb A, Gay F, Jauréguiberry S, et al. Epidemiologic trends in malaria incidence among travelers returning to Metropolitan France, 1996–2016. JAMA Netw Open. 2019;2:e191691.CrossRef
2.
go back to reference Tatem AJ, Jia P, Ordanovich D, Falkner M, Huang Z, Howes R, et al. The geography of imported malaria to non-endemic countries: a meta-analysis of nationally reported statistics. Lancet Infect Dis. 2017;17:98–107.CrossRef Tatem AJ, Jia P, Ordanovich D, Falkner M, Huang Z, Howes R, et al. The geography of imported malaria to non-endemic countries: a meta-analysis of nationally reported statistics. Lancet Infect Dis. 2017;17:98–107.CrossRef
3.
go back to reference WHO. World malaria report. Geneva: World Health Organization; 2018. WHO. World malaria report. Geneva: World Health Organization; 2018.
4.
go back to reference Baird JK. Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev. 2013;26:36–57.CrossRef Baird JK. Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev. 2013;26:36–57.CrossRef
5.
go back to reference Naing C, Whittaker MA, Wai VN, Mak JW. Is Plasmodium vivax malaria a severe malaria?: a systematic review and meta-analysis. PLoS Neglect Trop Dis. 2014;8:e3071.CrossRef Naing C, Whittaker MA, Wai VN, Mak JW. Is Plasmodium vivax malaria a severe malaria?: a systematic review and meta-analysis. PLoS Neglect Trop Dis. 2014;8:e3071.CrossRef
6.
go back to reference Rahimi BA, Thakkinstian A, White NJ, Sirivichyaku C, Dondorp AM, Chokeijindachai W. Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900. Malar J. 2014;13:481.CrossRef Rahimi BA, Thakkinstian A, White NJ, Sirivichyaku C, Dondorp AM, Chokeijindachai W. Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900. Malar J. 2014;13:481.CrossRef
7.
go back to reference Park SY, Park YS, Park Y, Kwak YG, Song JE, Lee KS, et al. Severe vivax malaria in the Republic of Korea during the period 2000 to 2016. Travel Med Infect Dis. 2019;30:108–13.CrossRef Park SY, Park YS, Park Y, Kwak YG, Song JE, Lee KS, et al. Severe vivax malaria in the Republic of Korea during the period 2000 to 2016. Travel Med Infect Dis. 2019;30:108–13.CrossRef
8.
go back to reference Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol. 1993;58:283–92.CrossRef Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol. 1993;58:283–92.CrossRef
10.
go back to reference Broderick C, Nadjm B, Smith V, Blaze M, Checkley A, Chiodini PL, et al. Clinical, geographical, and temporal risk factors associated with presentation and outcome of vivax malaria imported into the United Kingdom over 27 years: observational study. BMJ. 2015;350:h1703.CrossRef Broderick C, Nadjm B, Smith V, Blaze M, Checkley A, Chiodini PL, et al. Clinical, geographical, and temporal risk factors associated with presentation and outcome of vivax malaria imported into the United Kingdom over 27 years: observational study. BMJ. 2015;350:h1703.CrossRef
11.
go back to reference Wångdahl A, Wyss K, Saduddin D, Bottai M, Ydring E, Vikerfors T, et al. Severity of Plasmodium falciparum and non-falciparum malaria in travelers and migrants: a nationwide observational study over 2 decades in Sweden. J Infect Dis. 2019;220:1335–45.CrossRef Wångdahl A, Wyss K, Saduddin D, Bottai M, Ydring E, Vikerfors T, et al. Severity of Plasmodium falciparum and non-falciparum malaria in travelers and migrants: a nationwide observational study over 2 decades in Sweden. J Infect Dis. 2019;220:1335–45.CrossRef
12.
go back to reference Song JY, Park CW, Jo YM, Kim JY, Yoon HJ, Kim CH, et al. Two cases of Plasmodium vivax malaria with the clinical picture resembling toxic shock. Am J Trop Med Hyg. 2007;77:609–11.CrossRef Song JY, Park CW, Jo YM, Kim JY, Yoon HJ, Kim CH, et al. Two cases of Plasmodium vivax malaria with the clinical picture resembling toxic shock. Am J Trop Med Hyg. 2007;77:609–11.CrossRef
13.
go back to reference WHO. Guidelines for the treatment of malaria. 2nd ed. Geneva: World Health Organization; 2010. WHO. Guidelines for the treatment of malaria. 2nd ed. Geneva: World Health Organization; 2010.
14.
go back to reference WHO. Severe malaria. Trop Med Int Health. 2014;19(Suppl 1):7–131. WHO. Severe malaria. Trop Med Int Health. 2014;19(Suppl 1):7–131.
15.
go back to reference Seringe E, Thellier M, Fontanet A, Legros F, Bouchaud O, Ancelle T, et al. Severe imported Plasmodium falciparum malaria, France, 1996–2003. Emerg Infect Dis. 2011;17:807–13.CrossRef Seringe E, Thellier M, Fontanet A, Legros F, Bouchaud O, Ancelle T, et al. Severe imported Plasmodium falciparum malaria, France, 1996–2003. Emerg Infect Dis. 2011;17:807–13.CrossRef
16.
go back to reference Legros F, Bouchaud O, Ancelle T, Arnaud A, Cojean S, Le Bras J, et al. Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996–2003. Emerg Infect Dis. 2007;13:883–8.CrossRef Legros F, Bouchaud O, Ancelle T, Arnaud A, Cojean S, Le Bras J, et al. Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996–2003. Emerg Infect Dis. 2007;13:883–8.CrossRef
17.
go back to reference Descheemaeker PN, Mira JP, Bruneel F, Houze S, Tanguy M, Gangneux JP, et al. Near fatal multiple organ dysfunction syndrome induced by Plasmodium malariae. Emerg Infect Dis. 2009;15:832–3.CrossRef Descheemaeker PN, Mira JP, Bruneel F, Houze S, Tanguy M, Gangneux JP, et al. Near fatal multiple organ dysfunction syndrome induced by Plasmodium malariae. Emerg Infect Dis. 2009;15:832–3.CrossRef
18.
go back to reference White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297.CrossRef White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297.CrossRef
19.
go back to reference Battle KE, Karhunen MS, Bhatt S, Gething PW, Howes RE, Golding N, et al. Geographical variation in Plasmodium vivax relapse. Malar J. 2014;13:144.CrossRef Battle KE, Karhunen MS, Bhatt S, Gething PW, Howes RE, Golding N, et al. Geographical variation in Plasmodium vivax relapse. Malar J. 2014;13:144.CrossRef
20.
go back to reference Nishiura H, Lee HW, Cho SH, Lee WG, In TS, Moon SU, et al. Estimates of short- and long-term incubation periods of Plasmodium vivax malaria in the Republic of Korea. Trans R Soc Trop Med Hyg. 2007;101:338–43.CrossRef Nishiura H, Lee HW, Cho SH, Lee WG, In TS, Moon SU, et al. Estimates of short- and long-term incubation periods of Plasmodium vivax malaria in the Republic of Korea. Trans R Soc Trop Med Hyg. 2007;101:338–43.CrossRef
21.
go back to reference White NJ. The rise and fall of long-latency Plasmodium vivax. Trans R Soc Trop Med Hyg. 2019;113:163–8.CrossRef White NJ. The rise and fall of long-latency Plasmodium vivax. Trans R Soc Trop Med Hyg. 2019;113:163–8.CrossRef
22.
go back to reference Kondrashin AV, Morozova LF, Stepanova EV, Turbabina NA, Maksimova MS, Morozov EN. On the epidemiology of Plasmodium vivax malaria: past and present with special reference to the former USSR. Malar J. 2018;17:346.CrossRef Kondrashin AV, Morozova LF, Stepanova EV, Turbabina NA, Maksimova MS, Morozov EN. On the epidemiology of Plasmodium vivax malaria: past and present with special reference to the former USSR. Malar J. 2018;17:346.CrossRef
23.
go back to reference Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis. 2007;195:927–33.CrossRef Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis. 2007;195:927–33.CrossRef
24.
go back to reference Chen N, Auliff A, Rieckmann K, Gatton M, Cheng Q. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J Infect Dis. 2007;195:934–41.CrossRef Chen N, Auliff A, Rieckmann K, Gatton M, Cheng Q. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J Infect Dis. 2007;195:934–41.CrossRef
25.
go back to reference Orjuela-Sánchez P, da Silva NS, da Silva-Nunes M, Ferreira MU. Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia. Am J Trop Med Hyg. 2009;81:961–8.CrossRef Orjuela-Sánchez P, da Silva NS, da Silva-Nunes M, Ferreira MU. Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia. Am J Trop Med Hyg. 2009;81:961–8.CrossRef
26.
go back to reference Zhong D, Bonizzoni M, Zhou G, Wang G, Chen B, Vardo-Zalik A, et al. Genetic diversity of Plasmodium vivax malaria in China and Myanmar. Infect Genet Evol. 2011;11:1419–25.CrossRef Zhong D, Bonizzoni M, Zhou G, Wang G, Chen B, Vardo-Zalik A, et al. Genetic diversity of Plasmodium vivax malaria in China and Myanmar. Infect Genet Evol. 2011;11:1419–25.CrossRef
27.
go back to reference Noviyanti R, Coutrier F, Utami RA, Trimarsanto H, Tirta YK, Trianty L, et al. Contrasting transmission dynamics of co-endemic Plasmodium vivax and P. falciparum: implications for malaria control and elimination. PLoS Negl Trop Dis. 2015;9:e0003739.CrossRef Noviyanti R, Coutrier F, Utami RA, Trimarsanto H, Tirta YK, Trianty L, et al. Contrasting transmission dynamics of co-endemic Plasmodium vivax and P. falciparum: implications for malaria control and elimination. PLoS Negl Trop Dis. 2015;9:e0003739.CrossRef
28.
go back to reference Imwong M, Boel ME, Pagornrat W, Pimanpanarak M, McGready R, Day NP, et al. The first Plasmodium vivax relapses of life are usually genetically homologous. J Infect Dis. 2012;205:680–3.CrossRef Imwong M, Boel ME, Pagornrat W, Pimanpanarak M, McGready R, Day NP, et al. The first Plasmodium vivax relapses of life are usually genetically homologous. J Infect Dis. 2012;205:680–3.CrossRef
29.
go back to reference Chu CS, White NJ. Management of relapsing Plasmodium vivax malaria. Expert Rev Anti-Infect Ther. 2016;14:885–900.CrossRef Chu CS, White NJ. Management of relapsing Plasmodium vivax malaria. Expert Rev Anti-Infect Ther. 2016;14:885–900.CrossRef
30.
Metadata
Title
Plasmodium vivax severe imported malaria in two migrants in France
Authors
Arezki Izri
Sandrine Cojean
Claire Leblanc
Yves Cohen
Olivier Bouchaud
Rémy Durand
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2019
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-019-3067-5

Other articles of this Issue 1/2019

Malaria Journal 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.